Kale MR, Baig MS, Lamb A. A prospective observational pharmacovigilance study of adverse drug reaction monitoring in patients of tuberculosis receiving category I and II treatment regimens at tertiary care hospital. Int J Basic Clin Pharmacol [Internet]. 2019 Apr. 23 [cited 2025 Oct. 12];8(5):875-80. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/2748